z-logo
open-access-imgOpen Access
The Increased Plasma Levels of Intermedin in Patients with Type 2 Diabetes Mellitus
Author(s) -
F Liu,
Junting Duan,
Xu Teng,
Ding-Qiong Peng
Publication year - 2022
Publication title -
acta endocrinologica (bucharest)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.249
H-Index - 13
eISSN - 1843-066X
pISSN - 1841-0987
DOI - 10.4183/aeb.2022.271
Subject(s) - medicine , postprandial , type 2 diabetes mellitus , endocrinology , triglyceride , gastroenterology , diabetes mellitus , receiver operating characteristic , cholesterol
Intermedin (IMD) is the member of calcitonin gene-related peptide family, and tightly associated with type 2 diabetes mellitus (T2DM). The change of plasma IMD levels in T2DM is still unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom